Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
about
Protecting against plague: towards a next-generation vaccinePlague Vaccine Development: Current Research and Future TrendsBacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for miceProtein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion systemHuman anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague modelMulti-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative BacteriaBroad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.Immune defense against pneumonic plagueEfficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plagueThe smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infectionAntibiotic treatment of experimental pneumonic plague in miceGenome sequence of the deep-rooted Yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacteriumAnalysis of the Yersinia pestis V protein for the presence of linear antibody epitopesMultiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice.Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.Human immune response to a plague vaccine comprising recombinant F1 and V antigens.The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague.Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis.Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase.Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housing.LcrV plague vaccine with altered immunomodulatory propertiesProtective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestisImmune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice.A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challengeProtective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.Contributions of chaperone/usher systems to cell binding, biofilm formation and Yersinia pestis virulence.Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestisAdvanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.Plague bacteria target immune cells during infectionEffect of Yersinia pestis YopM on experimental plague.Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10.Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred miceHumoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.Intraspecific diversity of Yersinia pestis.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.New age adjuvants and delivery systems for subunit vaccines.
P2860
Q26823422-03AB7BB7-3974-4F4A-BC58-4F26F83CAE2EQ28066875-83B3BE9D-F278-4201-A810-3D8A258481BCQ28477274-C6C45B62-C915-43FD-A734-774B315EA95FQ28492902-BE59B206-C698-452B-8888-871995AD63C4Q28748886-D291B6CC-BD7A-4986-889C-11CA74965200Q30431366-2901C865-C996-4625-A8FC-B53D294A7AFBQ33310431-ABF0B16F-CAFF-4AC9-905C-B56A78241559Q33483363-147A1CD8-C17F-41A2-AD9B-BBD46F498385Q33584403-1329BE53-2D1D-4414-8119-B3C5883C2BDDQ33635050-AEFC67F2-867A-4881-8222-3A8AB2B4FCF0Q33637474-E6BF66C9-0BC1-41AD-B2B9-300320A90939Q33675834-264BBB36-DC22-4EB9-BF7B-0B20AAAC00D3Q33691477-B39EDACE-595B-43D8-A686-D0984AF650A6Q33705164-E879E4F9-F30E-40DE-AE60-14DCF9C5AB02Q33750146-DD03E957-E3DD-482B-9B5B-798C3E08B28BQ33786763-4355547A-A9B9-43C6-8A5C-E9A49F729AAAQ33788149-3DF8C95D-A02D-471A-8ED0-7FB2119CAB79Q33788286-1D10FA6D-D420-4601-A256-0C32B017D959Q33826085-6D84D3BE-F370-4159-91C2-4252A16B3A00Q33844730-4A6191B5-08AD-466A-9A33-C648ABB26D08Q33911034-C7DFF5B3-4D7F-43BF-BE44-BD7CC10CD665Q33934619-C1115E2A-B598-4DAC-B0B6-88A050283ED3Q33946882-64B74A35-162B-47AB-9C7C-D425AC761FA4Q34000759-B2E902C9-488C-4C23-8CCF-39ED0C210450Q34000948-6F5D2EF0-02F2-4D54-9158-3F14E6994848Q34016105-F628ED2A-4B86-4F4A-A2D4-F9C0FA9474A3Q34123275-F4109F8B-FA6E-4F48-A0F3-75D1209C5DD3Q34778198-364373C2-5F87-4F6F-874B-19713827261EQ34837374-240BA514-D864-4D2D-BD9B-61E1ECF7EE20Q35090599-0B7C818E-44B6-4DFE-8528-7D884B1BAE14Q35418294-34F8007A-1C4E-4508-B504-B687B3AB108FQ35535438-8891568A-234C-4023-A6E5-FFDA3C695089Q35544027-3159676A-78E8-475F-AE3F-949CBB582F0EQ35545012-860C308D-A634-42F8-AB70-B98E316D352BQ35689282-E379218D-6395-4FD6-BA4D-E31EF2FF7BA2Q35739128-89723787-A2DB-4FE4-B5E1-955DE0B84A2FQ35745842-F0823A42-F06F-4B67-8DA1-E5CFBF4640ECQ35783560-E077C49D-C179-4AA3-BE99-63DE3ACA48E9Q36237899-B071B7D7-4009-4156-AAF2-884816B22873Q36265526-50379EA2-EC49-4EAA-991A-7BD2969E0F1E
P2860
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@ast
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@en
type
label
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@ast
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@en
prefLabel
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@ast
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@en
P2093
P2860
P1476
Recombinant V antigen protects ...... ve strains of Yersinia pestis.
@en
P2093
Anderson GW Jr
Friedlander AM
Titball RW
Williamson ED
Worsham PL
P2860
P304
P407
P577
1996-11-01T00:00:00Z